Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "CF"

201 News Found

MSD launches cervical cancer awareness campaign with Madhuri Dixit Nene
News | May 06, 2026

MSD launches cervical cancer awareness campaign with Madhuri Dixit Nene

The initiative aims to encourage women and parents to seek timely medical guidance on cervical cancer prevention and HPV awareness


SK Capital sells Noramco assets to Siegfried
News | May 05, 2026

SK Capital sells Noramco assets to Siegfried

Keeps Halo Pharma to drive independent growth


Pawan Varshney elevated to Director of Finance – South Asia at Cepheid
People | May 01, 2026

Pawan Varshney elevated to Director of Finance – South Asia at Cepheid

His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia


Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer
Hospitals | May 01, 2026

Livasa Hospitals appoints Kamal Kant Gambhir as Chief Financial Officer

Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership


Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu
Hospitals | April 30, 2026

Apollo TeleHealth expands integrated healthcare services to Sri City in Tamil Nadu

New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities


Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet
News | April 25, 2026

Bayer’s comeback gains speed as CEO warns: “The Work Isn’t Complete. Yet"

The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before


Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
Supply Chain | April 17, 2026

Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion

The company allocated €56 million to research and development for next-generation line solutions


Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Drug Approval | April 17, 2026

Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection

Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions


Alpha Cognition secures key US patent for traumatic brain injury treatment
Biopharma | April 08, 2026

Alpha Cognition secures key US patent for traumatic brain injury treatment

The patent, titled “ALPHA-1062 for treating Traumatic Brain Injury,” strengthens Alpha Cognition’s existing portfolio supporting both ALPHA-1062 and ZUNVEYL


Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027
Biotech | April 02, 2026

Vyome Holdings bolsters financial position to support VT-1953 pivotal study through 2027

As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million